Morgan Stanley raises United Therapeutics price target to $566
Morgan Stanley raised its price target on United Therapeutics to $566.00 per share from $515.00, according to Benzinga.
Story updates
03:19:31 PM UTC
SquawkNews
United Therapeutics Price Target Raised to $566.00/Share From $515.00 by Morgan Stanley